Cositecan is the novel camptothecin derivative which is also known as Karenitecin. It has been developed for superior oral bioavailability and increased lactone stability. It is used to treat cancer.
Investigated for use/treatment in brain cancer, lung cancer, and melanoma.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.